A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly

Journal of Lipid Research

Volumn 45, Issue 5, 2004, Pages 948-953

  Curb, J D ^a,b,c   Abbott, R D ^a,d   Rodriguez, B L ^a,b,c   Masaki, K ^a,b,c   Chen, R ^a   Sharp, D S ^e   Tall, A R ^f  

^a PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^b KUAKINI MEDICAL CENTER   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^f Howard Hughes Medical Institute   (United States)

Author keywords

Epidemiology; High density lipoprotein cholesterol; Risk factors

Indexed keywords

CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL TRANSPORT; FOLLOW UP; GENE MUTATION; GENETIC VARIABILITY; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

AGE FACTORS; AGED; AGED, 80 AND OVER; ASIAN AMERICANS; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; CHOLESTEROL ESTERS; CHOLESTEROL, HDL; CORONARY DISEASE; GENETIC PREDISPOSITION TO DISEASE; GLYCOPROTEINS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTICENTER STUDIES; MUTATION; PROSPECTIVE STUDIES;

EID: 2142763867     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300520-JLR200     Document Type: Article

References (40)

1. Castelli, W. P., J. T. Doyle, T. Gordon, C. G. Hames, M. C. Hjortland, S. B. Hulley, A. Kagan, and W. J. Zukel. 1977. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation. 55: 767-772.
2. Abbott, R. D., P. W. Wilson, W. B. Kannel, and W. P. Castelli. 1988. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study. Arteriosclerosis. 8: 207-211.
3. Gordon, D. J., and B. M. Rifkind. 1989. High-density lipoprotein - the clinical implications of recent studies. N. Engl. J. Med. 321: 1311-1316.
4. Stampfer, M. J., F. M. Sacks, S. Salvini, W. C. Willett, and C. H. Hennekens. 1991. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N. Engl. J. Med. 325: 373-381.
5. Pekkanen, J., S. Linn, G. Heiss, C. M. Suchindran, A. Leon, B. M. Rifkind, and H. A. Tyroler. 1990. Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease. N. Engl. J. Med. 322:1700-1707.
6. Assmann, G., H. Schulte, A. von Eckardstein, and Y. Huang. 1996. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis. 124 (Suppl.): S11-S20.
7. Kitamura, A., H. Iso, Y. Naito, M. Iida, M. Konishi, A. R. Folsom, S. Sato, M. Kiyama, M. Nakamura, and T. Sankai. 1994. High-density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation. 89: 2533-2539.
8. Corti, M. C., J. M. Guralnik, M. E. Salive, T. Harris, T. S. Field, R. B. Wallace, L. F. Berkman, T. E. Seeman, R. J. Glynn, and C. H. Hennekens. 1995. HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA. 274: 539-544.
9. Zimetbaum, P., W. H. Frishman, W. L. Ooi, M. P. Derman, M. Aronson, L. I. Gidez, and H. A. Eder. 1992. Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study. Arterioscler. Thromb. 12: 416-423.
10. Rhoads, G. G., C. L. Gulbrandsen, and A. Kagan. 1976. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N. Engl. J. Med. 294: 293-298.
11. Lusis, A. J. 2000. Atherosclerosis. Nature. 407: 233-241.
12. Tall, A. R. 1990. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J. Clin. Invest. 86: 379-384.
13. Zhong, S., D. S. Sharp, J. S. Grove, C. Bruce, K. Yano, J. D. Curb, and A. R. Tall. 1996. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J. Clin. Invest. 97: 2917-2923.
14. Abbott, R. D., B. L. Rodriguez, C. M. Burchfiel, and J. D. Curb. 1994. Physical activity in older middle-aged men and reduced risk of stroke: the Honolulu Heart Program. Am. J. Epidemiol. 139: 881-893.
15. Kagan, A., B. R. Harris, W. Winkelstein, Jr., K. G. Johnson, H. Kato, S. L. Syme, G. G. Rhoads, M. L. Gay, M. Z. Nichaman, H. B. Hamilton, and J. Tillotson. 1974. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics. J. Chronic Dis. 27: 345-364.
16. Worth, R. M., and A. Kagan. 1970. Ascertainment of men of Japanese ancestry in Hawaii through World War II Selective Service registration. J. Chronic Dis. 23: 389-397.
17. Fried, L. P., N. O. Borhani, P. Enright, C. D. Furberg, J. M. Gardin, R. A. Kronmal, L. H. Kuller, T. A. Manolio, M. B. Mittelmark, and A. Newman. 1991. The Cardiovascular Health Study: design and rationale. Ann. Epidemiol. 1: 263-276.
18. Lane, P. W., and J. A. Nelder. 1982. Analysis of covariance and standardization as instances of prediction. Biometrics. 38: 613-621.
19. Cox, D. R. 1972. Regression models and life tables. J. Roy. Stat. Soc. 34: 187-202.
20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 2001. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 285: 2486-2497.
21. Reed, D., and R. Benfante. 1992. Lipid and lipoprotein predictors of coronary heart disease in elderly men in the Honolulu Heart Program. Ann. Epidemiol. 2: 29-34.
22. Krumholz, H. M., T. E. Seeman, S. S. Merrill, C. F. Mendes de Leon, V. Vaccarino, D. I. Silverman, R. Tsukahara, A. M. Ostfeld, and L. F. Berkman. 1994. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years. JAMA. 272: 1335-1340.
23. Barrett-Connor, E. 1992. Hypercholesterolemia predicts early death from coronary heart disease in elderly men but not women. The Rancho Bernardo Study. Ann. Epidemiol. 2: 77-83.
24. Moriyama, Y., T. Okamura, A. Inazu, M. Doi, H. Iso, Y. Mouri, Y. Ishikawa, H. Suzuki, M. Iida, J. Koizumi, H. Mabuchi, and Y. Komachi. 1998. A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency. Prev. Med. 27: 659-667.
25. Hirano, K., S. Yamashita, Y. Kuga, N. Sakai, S. Nozaki, S. Kihara, T. Arai, K. Yanagi, S. Takami, and M. Menju. 1995. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. Arterioscler. Thromb. Vasc. Biol. 15: 1849-1856.
26. Hirano, K., S. Yamashita, N. Nakajima, T. Arai, T. Maruyama, Y. Yoshida, M. Ishigami, N. Sakai, K. Kameda-Takemura, and Y. Matsuzawa. 1997. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity. Aterioscler. Thromb. Vasc. Biol. 17: 1053-1059.
27. Fumeron, F., D. Betoulle, G. Luc, I. Behague, S. Ricard, O. Poirier, R. Jemaa, A. Evans, D. Arveiler, and P. Marques-Vidal. 1995. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J. Clin. Invest. 96: 1664-1671.
28. Agerholm-Larsen, B., A. Tybjaerg-Hansen, P. Schnohr, R. Steffensen, and B. G. Nordestgaard. 2000. Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease: The Copenhagen City Heart Study. Circulation. 102: 2197-2203.
29. Okamoto, H., F. Yonemori, K. Wakitani, T. Minowa, K. Maeda, and H. Shinkai. 2000. A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Nature. 406: 203-207.
30. Yamada, N., H. Shimano, and Y. Yazaki. 1995. Role of apolipoprotein E in lipoprotein metabolism and in the process of atherosclerosis. J. Atheroscler. Thromb. 2 (Suppl.): S29-S33.
31. Hayek, T., L. Masucci-Magoulas, X. Jiang, A. Walsh, E. Rubin, J. L. Breslow, and A. R. Tall. 1995. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J. Clin. Invest. 96: 2071-2074.
32. Masucci-Magoulas, L., I. J. Goldberg, C. L. Bisgaier, H. Serajuddin, O. L. Francone, J. L. Breslow, and A. R. Tall. 1997. A mouse model with features of familial combined hyperlipidemia. Science. 275: 391-394.
33. Bruce, C., R. A. Chouinard, Jr., and A. R. Tall. 1998. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu. Rev. Nutr. 18: 297-330.
34. Brown, M. L., A. Inazu, C. B. Hesler, L. B. Agellon, C. Mann, M. E. Whitlock, Y. L. Marcel, R. W. Milne, J. Koizumi, and H. Mabuchi. 1989. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature. 342: 448-451.
35. de Grooth, G. J., J. A. Kuivenhoven, A. F. Stalenhoef, J. de Graaf, A. H. Zwinderman, J. L. Posma, A. van Tol, and J. J. Kastelein. 2002. Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study. Circulation. 105: 2159-2165.
36. Parthasarathy, S., J. Barnett, and L. G. Fong. 1990. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta. 1044: 275-283.
37. Saxena, U., E. Ferguson, and C. L. Bisgaier. 1993. Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix. J. Biol. Chem. 268: 14812-14819.
38. Ishigami, M., S. Yamashita, N. Sakai, T. Arai, K. Hirano, H. Hiraoka, K. Kameda-Takemura, and Y. Matsuzawa. 1994. Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency cannot protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins. J. Biochem. (Tokyo). 116: 257-262.
39. Hannuksela, M. L., M. E. Brousseau, S. M. Meyn, H. Nazih, G. Bader, R. D. Shamburek, P. Alaupovic, and H. B. Brewer, Jr. 2002. In vivo metabolism of apolipoprotein E within the HDL subpopulations LpE, LpE:A-I, LpE:A-II and LpE:A-I:A-II. Atherosclerosis. 165: 205-220.
40. Schatz, I. J., K. Masaki, K. Yano, R. Chen, B. L. Rodriguez, and J. D. Curb. 2001. Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet. 358: 351-355.